Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa K Stamp

Showing results (41-50 of 293) with videos related to

Pageof 30
Sort By:
Seminars in Arthritis and Rheumatism|October 1, 2005
Diet and rheumatoid arthritis: a review of the literatureLisa K Stamp, Michael J James, Leslie G Cleland
Therapeutic Advances in Musculoskeletal Disease|August 28, 2025
The genetics of gout: translation into clinical practiceTony R Merriman, Fiorella Rosas-Chavez, Lisa K Stamp
The Journal of Rheumatology|July 2, 2004
Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alphaLisa K Stamp, Leslie G Cleland, Michael J James
The Lancet. Rheumatology|January 17, 2024
Making the right thing the easy thing to do: strategies to improve outcomes in goutNicola Dalbeth, Susan Reid, Lisa K Stamp, et al.
Joint Bone Spine|October 11, 2015
Allopurinol and kidney function: An updateLisa K Stamp, Peter T Chapman, Suetonia C Palmer
Expert Opinion on Emerging Drugs|September 25, 2018
Expert opinion on emerging urate-lowering therapiesLisa K Stamp, Tony R Merriman, Jasvinder A Singh
British Journal of Clinical Pharmacology|November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Immunology and Cell Biology|February 27, 2004
Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis?Lisa K Stamp, Michael J James, Leslie G Cleland
Scientific Reports|December 10, 2017
Digital-PCR for gene expression: impact from inherent tissue RNA degradationMelanie J Millier, Lisa K Stamp, Paul A Hessian
Rheumatology (Oxford, England)|April 21, 2010
Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?Ketna Parekh, Daniel Ching, Mahboob U Rahman, et al.
Pageof 30

Showing results (41-50 of 293) with videos related to

Sort By:
Pageof 30
Seminars in Arthritis and Rheumatism|October 1, 2005
Diet and rheumatoid arthritis: a review of the literatureLisa K Stamp, Michael J James, Leslie G Cleland
Therapeutic Advances in Musculoskeletal Disease|August 28, 2025
The genetics of gout: translation into clinical practiceTony R Merriman, Fiorella Rosas-Chavez, Lisa K Stamp
The Journal of Rheumatology|July 2, 2004
Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alphaLisa K Stamp, Leslie G Cleland, Michael J James
The Lancet. Rheumatology|January 17, 2024
Making the right thing the easy thing to do: strategies to improve outcomes in goutNicola Dalbeth, Susan Reid, Lisa K Stamp, et al.
Joint Bone Spine|October 11, 2015
Allopurinol and kidney function: An updateLisa K Stamp, Peter T Chapman, Suetonia C Palmer
Expert Opinion on Emerging Drugs|September 25, 2018
Expert opinion on emerging urate-lowering therapiesLisa K Stamp, Tony R Merriman, Jasvinder A Singh
British Journal of Clinical Pharmacology|November 14, 2018
Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!Lisa K Stamp, Daniel F B Wright, Nicola Dalbeth
Immunology and Cell Biology|February 27, 2004
Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis?Lisa K Stamp, Michael J James, Leslie G Cleland
Scientific Reports|December 10, 2017
Digital-PCR for gene expression: impact from inherent tissue RNA degradationMelanie J Millier, Lisa K Stamp, Paul A Hessian
Rheumatology (Oxford, England)|April 21, 2010
Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?Ketna Parekh, Daniel Ching, Mahboob U Rahman, et al.
Pageof 30